Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AGMKLNF 79 3-Year Share Buyback Ratio is -0.80 as of Jun. 2026. GuruFocus rates MKLNF with a GF Score™ of 79/100 and a GF Value™ of $6.20. The stock has 4 warning signs investors should review. Among 70 Medical Distribution companies, M1 Kliniken AG ranks worse than 52.86% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. M1 Kliniken AG's current 3-Year Share Buyback Ratio was -0.80%.
The historical rank and industry rank for M1 Kliniken AG's 3-Year Share Buyback Ratio or its related term are showing as below:
MKLNF'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -5.3 Med: -2 Max: -0.4
Current: -0.8
During the past 12 years, M1 Kliniken AG's highest 3-Year Share Buyback Ratio was -0.40%. The lowest was -5.30%. And the median was -2.00%.
MKLNF's 3-Year Share Buyback Ratio is ranked worse than 52.86% of 70
companies
in the Medical Distribution industry
Industry Median: -0.55
vs MKLNF: -0.80
M1 Kliniken AG (OTCPK:MKLNF) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
M1 Kliniken AG 3-Year Share Buyback Ratio Related Terms
MKLNF vs MCK, COR, CAH: 3-Year Share Buyback Ratio Comparison
For the Medical Distribution subindustry, M1 Kliniken AG's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG 3-Year Share Buyback Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's 3-Year Share Buyback Ratio falls into.
M1 Kliniken AG 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of -0.80 mean?
M1 Kliniken AG (MKLNF) has a 3-Year Share Buyback Ratio of -0.80 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for M1 Kliniken AG and its competitors. According to the industry distribution chart, M1 Kliniken AG ranks #37 out of 70 companies in the Medical Distribution industry, placing it in the top 52.9%.
Is M1 Kliniken AG's 3-Year Share Buyback Ratio too high?
M1 Kliniken AG's current 3-Year Share Buyback Ratio is -0.80. Based on the distribution chart, M1 Kliniken AG ranks #37 out of 70 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, M1 Kliniken AG has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's 3-Year Share Buyback Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #37 out of 70 companies for 3-Year Share Buyback Ratio. This places M1 Kliniken AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Distribution company?
A good 3-Year Share Buyback Ratio depends on the Medical Distribution industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for M1 Kliniken AG and its competitors. M1 Kliniken AG's current 3-Year Share Buyback Ratio is -0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current 3-Year Share Buyback Ratio of -0.80. The stock's GF Value™ is $6.20, compared to a current price of $11.73 — trading 89.2% above its estimated fair value. The current 3-Year Share Buyback Ratio is -0.80. M1 Kliniken AG's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current 3-Year Share Buyback Ratio is -0.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 89.2% above its estimated GF Value™ of $6.20.
Key valuation signals for MKLNF:
3-Year Share Buyback Ratio: -0.80
GF Value™: $6.20 vs. price of $11.73 (89.2% above fair value)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
79GF Score
Get the complete analysis for MKLNF
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
